研究者
J-GLOBAL ID:201801006952501875   更新日: 2022年10月01日

津田 恵

megumi tsuda
所属機関・部署:
論文 (7件):
  • Fukumori Tomoharu, Daizumoto Kei, Tsuda Megumi, Ozaki Keisuke, Kusuhara Yoshito, Mori Hidehisa, Fukawa Tomoya, Yamamoto Yasuyo, Yamaguchi Kunihisa, Takahashi Masayuki, et al. GALECTIN-3 IS INVOLVED IN THE TUMOR PROGRESSION AND DRUG RESISTANCE INDUCED BY TAXANE CHEMOTHERAPY AND POLY(ADENOSINE DIPHOSPHATE [ADP]-RIBOSE) POLYMERASE (PARP) INHIBITOR IN CASTRATION-RESISTANT PROSTATE CANCER. JOURNAL OF UROLOGY. 2019. 201. 4. E1176
  • Kusuhara Y, Daizumoto K, Kawai K, Hirayama K, Kowada M, Shintani T, Fukuhara Y, Dondoo TO, Ozaki K, Tsuda M, et al. Low Expression of Toll-like Receptor 4 Is Associated With Poor Prognosis in Bladder Cancer. Anticancer research. 2019. 39. 2. 703-711
  • Takahashi Masayuki, Daizumoto Kei, Fukuhara Yayoi, Ozaki Keisuke, Tsuda Megumi, Kusuhara Yoshito, Mori Hidehisa, Fukawa Tomoya, Yamamoto Yasuyo, Yamaguchi Kunihisa, et al. CORRELATION OF THE INSULIN RECEPTOR EXPRESSION AND THE RESISTANCE TO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS IN ADVANCED CLEAR CELL RENAL CELL CARCINOMA. JOURNAL OF UROLOGY. 2018. 199. 4. E954
  • Hidehisa Mori, Tomoharu Fukumori, Kei Daizumoto, Megumi Tsuda, Yoshihito Kusuhara, Tomoya Fukawa, Yasuyo Yamamoto, Kunihisa Yamaguchi, Masayuki Takahashi, Akiko Kubo, et al. Predictive Factors for Prolonged Urination Disorder After Permanent I-125 Brachytherapy for Localized Prostate Cancer. IN VIVO. 2017. 31. 4. 755-761
  • Takahashi Masayuki, Daizumoto Kei, Tsuda Megumi, Kusuhara Yoshito, Mori Hidehisa, Shintani Terumichi. Correlation of insulin-receptor expression with efficacy of axitinib in patients with advanced renal cell carcinoma. JOURNAL OF CLINICAL ONCOLOGY. 2017. 35. 6
もっと見る
MISC (156件):
※ J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。

前のページに戻る